The Clinical Proteomic Tumor Analysis Consortium (CPTAC) is pleased to announce its Virtual Scientific Symposium 2020, September 22nd, 2020. This year’s symposium will feature talks by leaders in the field of proteogenomics and will focus on CPTAC’s tumor characterization and translational studies for pediatric brain cancer, acute myeloid leukemia, and glycoproteomics – just to name a few!
The symposium will wrap-up with a Data Analysis Tool session to introduce attendees to much of the software developed by CPTAC researchers widely used in proteomic analysis today. The session will include live demos of proteomic and proteogenomic tools, and genomic and imaging tools.
Proteomics and proteogenomics have become an important factor in assessing cancer biology and precision oncology, earning a highlight in the National Cancer Institute’s (NCI’s) Annual Plan & Budget Proposal for fiscal year 2022. Proteomics, when layered with genomics and transcriptomics, gives a much deeper and more meaningful insight into how cancer behaves and, most importantly, reveals to us, new targets to treat cancer. CPTAC also provides a plethora of freely available resources and data that can assist researchers in their own proteomic analyses through the NCI Antibody Portal, NCI Assay Portal, Proteomic Data Commons, Genomic Data Commons and The Cancer Imaging Archive.
Registration is required. We hope you can join us!